HHS’ Becerra, once ‘invisible,’ races to bolster his legacy

Health secretary Xavier Becerra is finally making inroads with the White House. Is it enough to change his legacy?

January 9, 2024 Check out STAT+

Sponsored By

Illustration: Christine Kao/STAT; Photos: Getty HHS's Xavier Becerra, once an 'invisible' secretary, is racing to cement a clearer legacy Health secretary Xavier Becerra, once 'invisible,' is finally making inroads with the White House. Is it enough to change his legacy? By Sarah Owermohle STAT+ | FDA's Peter Marks seems inclined to grant full approval to Sarepta's Duchenne gene therapy At an event on the sidelines of the J.P. Morgan Healthcare Conference, Marks seemed comfortable with granting some form of full approval to Elevidys. By Adam Feuerstein STAT+ | Doudna institute hatches plan to 'cure hundreds of diseases' left behind by CRISPR revolution A new effort from the Nobel Prize winner's nonprofit looks to use genome editing to help patients with diseases too rare for industry to care. By Jason Mast Illustration: STAT; Photo Courtesy The Afghan father aided U.S. soldiers. Now Texas Medicaid won't pay for his son's gene therapy Orchard Therapeutics' Libmeldy is on the market in Europe, but Medicaid refused to cover the therapy because it's not approved in the U.S. By Megan Molteni STAT+ | Nvidia says a biological revolution is happening now. But is it? Why be skeptical? History. This isn't the first time that a new technology was supposed to improve drug hunters' success rate. By Matthew Herper STAT+ | JPM 2024: FogPharma's new CEO, Mathai Mammen, unveils 'contrarian' plan in oncology CEO Mathai Mammen plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers. By Allison DeAngelis Adobe Opinion: Sen. Maggie Hassan on what Congress must do next to fight the opioid crisis Congress must quickly reauthorize and expand the expired SUPPORT Act to fight the opioid crisis, writes Sen. Maggie Hassan (D-N.H.) By Maggie Hassan

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser